Chapman Peter Hume 4
4 · IonQ, Inc. · Filed Mar 11, 2025
Insider Transaction Report
Form 4
IonQ, Inc.IONQ
Chapman Peter Hume
DirectorExecutive Chair
Transactions
- Sale
Common Stock
2025-03-11$18.72/sh−2,000,000$37,446,600→ 414,363 total - Exercise/Conversion
Common Stock
2025-03-11$0.13/sh+1,528,394$198,691→ 1,942,757 total - Exercise/Conversion
Common Stock
2025-03-11$7.63/sh+471,606$3,598,354→ 2,414,363 total - Exercise/Conversion
Stock Option (right to buy)
2025-03-11−1,528,394→ 6,568,511 totalExercise: $0.13Exp: 2029-05-16→ Common Stock (1,528,394 underlying) - Exercise/Conversion
Stock Option (right to buy)
2025-03-11−471,606→ 235,334 totalExercise: $7.63Exp: 2032-08-17→ Common Stock (471,606 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.30 to $19.173, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]All of the shares subject to the option are fully vested and exercisable as of the date hereof.
- [F3]This option, originally for 706,940 shares, vests as to 1/16th of the shares on September 10, 2022 and quarterly thereafter on each subsequent December 10, March 10, June 10 and September 10, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.